These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33222292)

  • 41. Perceptions of healthcare professionals' support, shock anxiety and device acceptance among implantable cardioverter defibrillator recipients.
    Morken IM; Norekvål TM; Bru E; Larsen AI; Karlsen B
    J Adv Nurs; 2014 Sep; 70(9):2061-2071. PubMed ID: 24506575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subcutaneous Implantable Cardioverter Defibrillator: Early Experience.
    Souza FSO; Matos VS; Almeida MCV; Weiss SC; Rodrigues LHB; Lima PAG; Mattos DB
    Braz J Cardiovasc Surg; 2017; 32(6):498-502. PubMed ID: 29267613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on implantable cardioverter defibrillators: knowing the differences in devices and their impact on patient care.
    Nichols K; Collins J
    AACN Clin Issues; 1995 Feb; 6(1):31-43. PubMed ID: 7736302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organisation of care for Swedish patients with an implantable cardioverter defibrillator, a national survey.
    Bolse K; Johansson I; Strömberg A
    J Clin Nurs; 2011 Sep; 20(17-18):2600-8. PubMed ID: 20964752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life and psychological co-morbidities in children and adolescents with cardiac pacemakers and implanted defibrillators: a cohort study in Eastern Germany.
    Paech C; Ebel V; Wagner F; Stadelmann S; Klein AM; Döhnert M; Dähnert I; Gebauer RA
    Cardiol Young; 2020 Apr; 30(4):549-559. PubMed ID: 32279696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families?
    Eckert M; Jones T
    Int J Nurs Pract; 2002 Jun; 8(3):152-7. PubMed ID: 12000634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of life and psychological status of patients with implantable cardioverter defibrillators.
    Thomas SA; Friedmann E; Kao CW; Inguito P; Metcalf M; Kelley FJ; Gottlieb SS
    Am J Crit Care; 2006 Jul; 15(4):389-98. PubMed ID: 16823016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with anxiety and depression among patients with implantable cardioverter defibrillator.
    Wong MF
    J Clin Nurs; 2017 May; 26(9-10):1328-1337. PubMed ID: 27859926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
    Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
    Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Rosi IM; Bombardieri F; Steri D; Sternativo M; Rancati S
    Clin Nurs Res; 2021 Jun; 30(5):616-624. PubMed ID: 33103473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation.
    Grimm M; Wieselthaler G; Avanessian R; Grimm G; Schmidinger H; Schreiner W; Podczeck A; Wolner E; Laufer G
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):532-9. PubMed ID: 7637372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normativity under change: Older persons with implantable cardioverter defibrillator.
    Svanholm JR; Nielsen JC; Mortensen PT; Christensen CF; Birkelund R
    Nurs Ethics; 2016 May; 23(3):328-38. PubMed ID: 25566813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.
    Anderson MH; Camm AJ
    Br Heart J; 1993 Jan; 69(1):83-92. PubMed ID: 8457402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.